(FTD) |
0 (0%) 04-20 02:28 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
sell | buy |
Resistance 2: | 56.65 |
Resistance 1: | 55.48 |
Pivot price: | 55.15 |
Support 1: | 53.59 |
Support 2: | 44.59 |
52w High: | |
52w Low: |
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | 0.0 |
Return on Equity (ttm) | 0.0 |
Wed, 17 Apr 2024
Not All Forms of PPA Are FTD, as Recent High-Profile Case Highlights - AFTD
Wed, 17 Apr 2024
AFTD Ambassador Honors Daughter by Spreading FTD Awareness: “FTD Didn't Win in the End” - AFTD
Wed, 17 Apr 2024
Lexeo Therapeutics announces U.S. FDA granted FTD to LX2006 - TipRanks.com - TipRanks
Tue, 16 Apr 2024
AviadoBio treats first subject in trial of FTD-GRN therapy - Clinical Trials Arena
Mon, 15 Apr 2024
AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal ... - Business Wire
Fri, 05 Apr 2024
Dementia: Smartphone app accurately detects early-onset in new study - Medical News Today
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |